VALENCE, France--(BUSINESS WIRE)--Regulatory News:
Amplitude Surgical (Paris:AMPLI) (ISIN: FR0012789667, Ticker: AMPLI, PEA-PME eligible), a leading French player on the global surgical technology market for lower-limb orthopedics, today announces its schedule for the publication of financial information for 2015-16 results and 2016-17.
|2015-16 Full-Year Results||Thursday October 6, 2016|
|2016-17 Q1 Sales||Wednesday November 23, 2016|
|2016-17 H1 Sales||Wednesday February 15, 2017|
|2016-17 H1 Results||Wednesday March 22, 2017|
|2016-17 Q3 Sales||Wednesday April 26, 2017|
|2016-17 Full-Year Sales||Wednesday July 26, 2017|
|2016-17 Full-Year Results||Wednesday October 18, 2017|
* Subject to modification. Press releases are published after market closes.
Next financial press release: 2015-16 annual results, on Thursday October 6, 2016, after market.
About Amplitude Surgical
Founded in 1997 in Valence, France, Amplitude Surgical is a leading French player on the global surgical technology market for lower-limb orthopedics. Amplitude Surgical develops and markets high-end products for orthopedic surgery covering the main disorders affecting the hip, knee and extremities, and notably foot and ankle surgery. Amplitude Surgical develops, in close collaboration with surgeons, numerous high value-added innovations in order to best meet the needs of patients, surgeons and healthcare facilities. A leading player in France, Amplitude Surgical is developing abroad through its subsidiaries and a network of exclusive distributors and agents. Amplitude Surgical operates on the lower-limb market through the intermediary of its Novastep subsidiaries in France and the United States. Amplitude Surgical distributes its products in more than 30 countries. On June 30, 2016, Amplitude Surgical had a workforce of nearly 290 staff and recorded sales of over 80 million euros.